Masuda Jun-Ichi, Omagari Katsuhisa, Ohba Kazuo, Hazama Hiroaki, Kadokawa Yoshiko, Kinoshita Hideki, Hayashida Kenji, Hayashida Kazuhiro, Ishibashi Hiromi, Nakanuma Yasuni, Kohno Shigeru
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Dig Dis Sci. 2003 May;48(5):932-8. doi: 10.1023/a:1023055714208.
Although anti-mitochondrial antibody (AMA) is the characteristic serological feature of primary biliary cirrhosis (PBC), its pathogenetic role remains unclear. We tested sera from 72 Japanese patients with histologically confirmed PBC for AMA by indirect immunofluorescence, anti-pyruvate dehydrogenase complex (PDC) by enzyme inhibition assay, immunoglobulin (Ig) G class anti-PDC by ELISA, and IgG, IgM, and IgA class anti-2-oxo-acid dehydrogenase complex (2-OADC) by immunoblotting. Of the 72 sera, 60 (83%), 50 (69%), 42 (58%), and 71 (99%) were positive for AMA by immunofluorescence, enzyme inhibition assay, ELISA, and immunoblotting, respectively. There was no significant correlation between histological stages and AMA by immunofluorescence, PDC inhibitory antibodies by enzyme inhibition assay, IgG class anti-PDC antibodies by ELISA, or IgG and IgM class anti-2-OADC by immunoblotting. IgA class anti-2-OADC by immunoblotting was more frequent in stages 2-4 than in stage 1 (P = 0.0083). Of the IgA class anti-2-OADC, anti-PDC-E2 (74 kDa) and anti-E3BP (52 kDa) were more frequent in stages 2-4 than in stage 1 (P = 0.0253 and 0.0042, respectively). Further examination of histopathological findings in 53 of 72 liver biopsy specimens showed that IgA class anti-PDC-E2 and IgA class anti-E3BP were associated with bile duct loss, and IgA class anti-PDC-E2 was also associated with interface hepatitis and atypical ductular proliferation. IgA is known to be secreted into the bile through biliary epithelial cells, implying that IgA class anti-PDC-E2 and E3BP may have a specific pathogenetic role during their transport into the bile by binding to their target antigen(s) in biliary epithelial cells, and this may be followed by dysfunction and finally destruction of biliary epithelial cells. Our present results suggest that these autoantibodies against 2-OADC detected by immunoblotting may be associated with the pathogenesis and pathologic progression of PBC.
尽管抗线粒体抗体(AMA)是原发性胆汁性肝硬化(PBC)的特征性血清学特征,但其致病作用仍不清楚。我们通过间接免疫荧光法检测了72例经组织学确诊为PBC的日本患者血清中的AMA,通过酶抑制试验检测抗丙酮酸脱氢酶复合物(PDC),通过酶联免疫吸附测定(ELISA)检测免疫球蛋白(Ig)G类抗PDC,通过免疫印迹法检测IgG、IgM和IgA类抗2-氧代酸脱氢酶复合物(2-OADC)。在这72份血清中,免疫荧光法、酶抑制试验、ELISA和免疫印迹法检测AMA阳性的分别有60份(83%)、50份(69%)、42份(58%)和71份(99%)。组织学分期与免疫荧光法检测的AMA、酶抑制试验检测的PDC抑制性抗体、ELISA检测的IgG类抗PDC抗体或免疫印迹法检测的IgG和IgM类抗2-OADC之间均无显著相关性。免疫印迹法检测的IgA类抗2-OADC在2-4期比1期更常见(P = 0.0083)。在IgA类抗2-OADC中,抗PDC-E2(74 kDa)和抗E3BP(52 kDa)在2-4期比1期更常见(分别为P = 0.0253和0.0042)。对72份肝活检标本中的53份进行组织病理学结果的进一步检查显示,IgA类抗PDC-E2和IgA类抗E3BP与胆管丢失有关,IgA类抗PDC-E2也与界面性肝炎和非典型小胆管增生有关。已知IgA通过胆管上皮细胞分泌到胆汁中,这意味着IgA类抗PDC-E2和E3BP在通过与胆管上皮细胞中的靶抗原结合而转运到胆汁的过程中可能具有特定的致病作用,随后可能导致胆管上皮细胞功能障碍并最终破坏。我们目前的结果表明,通过免疫印迹法检测到的这些抗2-OADC自身抗体可能与PBC的发病机制和病理进展有关。